WEBULL
WebtradeDownload

Is H&K (ENXTPA:MLHK) Undervalued Following Its Strong Half Year Results?

Simply Wall St · 1d ago

Why H&K stock is back in focus after half year earnings

H&K (ENXTPA:MLHK) moved into the spotlight after reporting half year 2026 results, with sales of €263.9 million, net income of €40.8 million and basic EPS from continuing operations of €1.15.

The strong half year 2026 report has coincided with a 1 month share price return of 7.04% and a 3 month share price return of 10.61% for H&K, suggesting short term momentum is improving even though the 1 year total shareholder return is down 34.09%.

Compare H&K's rebound with other companies showing improving price action and solid fundamentals by scanning our hand picked 258 high quality undervalued stocks today.

H&K now appears to be a stronger business based on recent figures, and the share price has reacted quickly. After this rebound, is the stock already pricing in that progress, or is the market still cautious about its valuation?

Price-to-earnings of 19.3x for H&K: Is it justified?

On a P/E of 19.3x, H&K trades below both the French Aerospace & Defense industry average of 28.8x and the broader European industry average of 33.9x. That pricing sits alongside a last close of €36.5 and a long term total shareholder return that is still down sharply over 1, 3 and 5 years.

The P/E ratio compares H&K's share price with its earnings per share and is a simple way to see how much investors are paying for each euro of current profit. For a company that reports a high return on equity of 32.4% and profit margins of 14.1% that are higher than last year's 7.4%, a lower than peer P/E suggests the market is assigning a more cautious earnings multiple than many competitors.

Compared with the French Aerospace & Defense industry at 28.8x and the broader European peer average at 33.9x, H&K's 19.3x P/E is materially lower. The stock is also screened as good value when compared with peer averages, even though Simply Wall St's DCF model currently estimates a future cash flow value of €0.36 per share, far below the current €36.5 share price. That mix points to a situation where earnings based metrics paint a more supportive picture than a strict cash flow model, and highlights why many investors cross check both approaches.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-earnings of 19.3x (UNDERVALUED)

However, investors still face risks if H&K's earnings falter or if sentiment stays weak after the long term total shareholder return declines across 1, 3 and 5 years.

Find out about the key risks to this H&K narrative.

Another view of H&K using the SWS DCF model

While H&K looks inexpensive on a P/E of 19.3x compared with industry averages, the SWS DCF model presents a very different perspective. It puts future cash flow value at just €0.36 per share, far below the current €36.5 price. This indicates a significant gap between the model’s valuation and the market price. How should you weigh that gap when judging the stock today?

Look into how the SWS DCF model arrives at its fair value.

MLHK Discounted Cash Flow as at Sep 2026
MLHK Discounted Cash Flow as at Sep 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out H&K for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 258 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With H&K showing both improving profitability metrics and a mixed long term share price record, sentiment is clearly split. Act while the data is fresh and form your own view by weighing the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond H&K?

H&K gives useful context, but your next move could come from a different corner of the market. Keep your watchlist fresh with new ideas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.